LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 23.10 | 84.90 | 1282 | 1616 | 0.7932 | 0.8939 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 23.10 | 84.90 | 1416 | 1616 | 0.8761 | 0.9387 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 24.81 | 84.90 | 15 | 1769 | 0.0085 | -0.3267 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 24.81 | 84.90 | 1466 | 1769 | 0.8285 | 0.9159 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 24.81 | 84.90 | 1422 | 1769 | 0.8036 | 0.9027 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 24.81 | 84.90 | 1527 | 1769 | 0.8630 | 0.9338 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 26.51 | 84.90 | 21 | 1923 | 0.0109 | -0.2668 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 26.51 | 84.90 | 1598 | 1923 | 0.8309 | 0.9194 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 26.51 | 84.90 | 1510 | 1923 | 0.7852 | 0.8954 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 26.51 | 84.90 | 1588 | 1923 | 0.8257 | 0.9167 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 28.21 | 84.90 | 32 | 2091 | 0.0153 | -0.1903 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 28.21 | 84.90 | 1714 | 2091 | 0.8195 | 0.9157 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 28.21 | 84.90 | 1675 | 2091 | 0.8009 | 0.9062 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 28.21 | 84.90 | 1742 | 2091 | 0.8329 | 0.9224 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 29.92 | 84.90 | 53 | 2237 | 0.0237 | -0.0950 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 29.92 | 84.90 | 1847 | 2237 | 0.8254 | 0.9203 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 29.92 | 84.90 | 1785 | 2237 | 0.7977 | 0.9065 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 29.92 | 84.90 | 1835 | 2237 | 0.8200 | 0.9177 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 31.62 | 84.90 | 58 | 2449 | 0.0237 | -0.0755 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 31.62 | 84.90 | 2077 | 2449 | 0.8479 | 0.9331 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 31.62 | 84.90 | 1968 | 2449 | 0.8034 | 0.9117 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 31.62 | 84.90 | 2006 | 2449 | 0.8189 | 0.9193 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 33.32 | 84.90 | 82 | 2722 | 0.0301 | -0.0069 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 33.32 | 84.90 | 2243 | 2722 | 0.8239 | 0.9241 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 33.32 | 84.90 | 2160 | 2722 | 0.7934 | 0.9096 | MN20160318_Q02 | G06 |